fbpx

neuropsychiatric drug development

29 09, 2021

Neuropsychiatric Drug Development (NDD)

2021-09-23T16:18:56+00:00September 29th, 2021|

Please join us this year and hear Dr. Zammit present, ''Trends in Substance Use Disorder Trials'' followed by a live 5 minute Q&A session after on September 29th, 2021 at 9:35am. The scarcity of new drugs for neuropsychiatric disorders contrasts with the extraordinary advances in neuroscience research to date. Focusing from bench to bedside, and [...]

22 02, 2021

ASENT Annual Meeting 2021

2020-12-21T21:50:00+00:00February 22nd, 2021|

The ASENT 2021 Annual Meeting is the only unique forum in American Neurology which brings together divergent areas of effort from industry, academia, advocacy, and government on one platform with open dialogue. We are pleased to welcome our faculty who include executive-level biohealth industry leaders, chairs of neurology and clinician-scientists from leading academic institutions from [...]

2 03, 2020

ASENT Annual Meeting

2020-02-21T22:41:06+00:00March 2nd, 2020|

The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.

23 07, 2019

Neuropsychiatric Drug Development (NPD)

2020-01-24T17:20:52+00:00July 23rd, 2019|

The 2nd Annual Neuropsychiatric Drug Development Summit (NPD) will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs.